Business Of Biotech
Claim This Podcastby Ben Comer
Podcast Authority
Beta
Podcast Overview
<p>The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.</p>
Language
🇺🇲
Publishing Since
4/14/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Business Of Biotech
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
May 4, 2026
From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.
Ionis Pharmaceuticals CEO Brett Monia, Ph.D., discusses the evolution of antisense oligonucleotide therapies and Ionis's strategic shift to a wholly-owned pipeline in this interview.
April 27, 2026
Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we talk with NervGen leaders Adam Rogers, M.D., and Rich Macary about NVG-291, a daily neuroreparative peptide designed to restore function in patients with spinal cord injuries. Adam talks about his strategy for the company after becoming CEO last July, including moving company trading from Canada's TSX Venture Exchange to the NASDAQ for better visibility, and making key hires for growt...
April 20, 2026
The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw
CFO and Board Director Allan Shaw discusses how FDA risk unpredictability reshapes biotech strategy and investor behavior in this interview.
312 total episodes available with 114 transcripts
Recent guests on Business Of Biotech
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Alan Bash
Guest
Rahul Aras
Guest
Thomas von Erlach
Guest
Monika Sumra
Guest
Jared Bauer
Guest
Cindy Perettie
Guest
Brian Hilberdink
Guest
Ron Cooper
Guest
Marc Salzberg
Guest
Kenneth Galbraith
Guest
Ken
Guest
Nick Manusos
Guest
Similar Podcasts
Discover related shows you might enjoy
Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
BioCentury This Week
BioCentury
The Long Run with Luke Timmerman
Timmerman Report
The Readout Loud
STAT
Biotech 2050 Podcast
Biotech 2050
The BioCentury Show
BioCentury
a16z Podcast
Andreessen Horowitz
Practical AI: Machine Learning, Data Science
Practical AI LLC
Invest Like the Best with Patrick O'Shaughnessy
Colossus | Investing & Business Podcasts
Capital Allocators – Inside the Institutional Investment Industry
Ted Seides – Allocator and Asset Management Expert
Training Data
Sequoia Capital
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
Odd Lots
Bloomberg
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
Harry Stebbings
Goldman Sachs Exchanges
Goldman Sachs
Deep-dive analytics for Business Of Biotech
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Business Of Biotech?
<p>The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.